This past week, the U.S. Food and Drug Administration took action by issuing recalls or warnings on six products it deemed had unknown dangers to consumers. Three of these were food products and three were prescription drugs.
Here, DrugNews recaps the various warnings and recalls you should know:
A recall was issued for the Krusteaz Blueberry Pancake Mix from Continental Mills manufactured between April and June of 2016 due to the possible presence of E. coli O121 contamination in the blueberry nuggets.
The 48oz. Deluxe S'mores Ice Cream sold in Kroger stores is being recalled due to the presence of an undisclosed peanut allergen.
Finally, Hearn Kirkwood is recalling certain batches of its Evie’s Cheddar Potato Salad sold in the Bellevue, WA locations of Amazon Fresh between April 8th and June 13th due to possible Listeria monocytogenes contamination of frozen peas used in the product.
Listeria is an infection that can cause severe symptoms or even death in young children or the elderly. It may also cause miscarriage or fetal death in pregnant women. However, it is usually only associated with short-term headache, fever, diarrhea, stiffness, nausea and abdominal pain.
A new box warning was added to the uric acid treatment Elitek due to post-approval reports that the drug may be linked to serious and fatal allergic reactions such as anaphylaxis.
Patients should speak with their doctor about their risks, and stop use immediately if a hypersensitivity reaction happens.
The seizure and spasm medication Sabril was given an additional label warning due to heightened risks that it may cause retina damage and permanent loss of vision in both eyes, including tunnel vision.
Lastly, the FDA added label warnings to the extended release diabetes drug Xigduo XR, based on reports that it may be linked to lactic acidosis. Lactic acidosis caused by metformin drugs has bee known to result in hospitalization or death.
For more on drug and product warnings and recalls, follow DrugNews.net.
FDA. Recalls, Market Withdrawals & Safety Alerts. (July 11, 2016). Retrieved from http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm509048.htm
The U.S. Food and Drug Administration has identified a troubling number of reports of both pancreatitis and liver damage among patients taking the popular rheumatoid arthritis drug Actemra.
Families suing drug maker GlaxoSmithKline over alleged birth defects from their anti-nausea medication Zofran have raised new charges that the company hid safety data from the FDA and is blocking evidence of false advertising.